Design and characterization of nanoparticulate drug delivery system containing the antiviral drug stavudine

Prakash Goudanavar, Thandava Krishna, Doddayya Hiremath, Rajgopal Udupi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Human immunodeficiency virus (HIV) is a lentivirus (a member of the retrovirus family) that causes acquired immunodeficiency syndrome (AIDS). Stavudine nanoparticles for oral delivery were pre- pared by emulsion droplet coalescence method, emulsion cross linking method, and double emulsion method. The prepared nanoparticles were characterized for particle size and the surface morphology, results revealed that nanoparticles were found to be discrete and spherical with the mean size range of 119.9- 69.9 nm. Encapsulation efficiency was in the range of 28.9 to 60.9%. The drug content was uniform and reproducible in each batch of nanoparticles. FTIR and DSC studies revealed no interactions between drug and excipients. In-vitro release profiles indicated that, irrespective of the polymer used, increase in concentration has drastically retarded the release of stavudine. The mechanism of drug release was Non-Fickian diffusion controlled first order kinetics for optimized formulation. Stability studies indicated that, the prepared nanoparticle remained more stable at room temperature after one month.

Original languageEnglish
Pages (from-to)1518-1522
Number of pages5
JournalLatin American Journal of Pharmacy
Volume31
Issue number10
Publication statusPublished - 01-12-2012

Fingerprint

Stavudine
Drug Delivery Systems
Nanoparticles
Antiviral Agents
Emulsions
Lentivirus
Excipients
Fourier Transform Infrared Spectroscopy
Retroviridae
Drug Interactions
Particle Size
Polymers
Acquired Immunodeficiency Syndrome
HIV
Temperature
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science
  • Drug Discovery

Cite this

Goudanavar, Prakash ; Krishna, Thandava ; Hiremath, Doddayya ; Udupi, Rajgopal. / Design and characterization of nanoparticulate drug delivery system containing the antiviral drug stavudine. In: Latin American Journal of Pharmacy. 2012 ; Vol. 31, No. 10. pp. 1518-1522.
@article{d1925a93e28241289949108c5caf0542,
title = "Design and characterization of nanoparticulate drug delivery system containing the antiviral drug stavudine",
abstract = "Human immunodeficiency virus (HIV) is a lentivirus (a member of the retrovirus family) that causes acquired immunodeficiency syndrome (AIDS). Stavudine nanoparticles for oral delivery were pre- pared by emulsion droplet coalescence method, emulsion cross linking method, and double emulsion method. The prepared nanoparticles were characterized for particle size and the surface morphology, results revealed that nanoparticles were found to be discrete and spherical with the mean size range of 119.9- 69.9 nm. Encapsulation efficiency was in the range of 28.9 to 60.9{\%}. The drug content was uniform and reproducible in each batch of nanoparticles. FTIR and DSC studies revealed no interactions between drug and excipients. In-vitro release profiles indicated that, irrespective of the polymer used, increase in concentration has drastically retarded the release of stavudine. The mechanism of drug release was Non-Fickian diffusion controlled first order kinetics for optimized formulation. Stability studies indicated that, the prepared nanoparticle remained more stable at room temperature after one month.",
author = "Prakash Goudanavar and Thandava Krishna and Doddayya Hiremath and Rajgopal Udupi",
year = "2012",
month = "12",
day = "1",
language = "English",
volume = "31",
pages = "1518--1522",
journal = "Latin American Journal of Pharmacy",
issn = "0326-2383",
publisher = "Colegio de Farmaceuticos de la Provincia de Buenos Aires",
number = "10",

}

Design and characterization of nanoparticulate drug delivery system containing the antiviral drug stavudine. / Goudanavar, Prakash; Krishna, Thandava; Hiremath, Doddayya; Udupi, Rajgopal.

In: Latin American Journal of Pharmacy, Vol. 31, No. 10, 01.12.2012, p. 1518-1522.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Design and characterization of nanoparticulate drug delivery system containing the antiviral drug stavudine

AU - Goudanavar, Prakash

AU - Krishna, Thandava

AU - Hiremath, Doddayya

AU - Udupi, Rajgopal

PY - 2012/12/1

Y1 - 2012/12/1

N2 - Human immunodeficiency virus (HIV) is a lentivirus (a member of the retrovirus family) that causes acquired immunodeficiency syndrome (AIDS). Stavudine nanoparticles for oral delivery were pre- pared by emulsion droplet coalescence method, emulsion cross linking method, and double emulsion method. The prepared nanoparticles were characterized for particle size and the surface morphology, results revealed that nanoparticles were found to be discrete and spherical with the mean size range of 119.9- 69.9 nm. Encapsulation efficiency was in the range of 28.9 to 60.9%. The drug content was uniform and reproducible in each batch of nanoparticles. FTIR and DSC studies revealed no interactions between drug and excipients. In-vitro release profiles indicated that, irrespective of the polymer used, increase in concentration has drastically retarded the release of stavudine. The mechanism of drug release was Non-Fickian diffusion controlled first order kinetics for optimized formulation. Stability studies indicated that, the prepared nanoparticle remained more stable at room temperature after one month.

AB - Human immunodeficiency virus (HIV) is a lentivirus (a member of the retrovirus family) that causes acquired immunodeficiency syndrome (AIDS). Stavudine nanoparticles for oral delivery were pre- pared by emulsion droplet coalescence method, emulsion cross linking method, and double emulsion method. The prepared nanoparticles were characterized for particle size and the surface morphology, results revealed that nanoparticles were found to be discrete and spherical with the mean size range of 119.9- 69.9 nm. Encapsulation efficiency was in the range of 28.9 to 60.9%. The drug content was uniform and reproducible in each batch of nanoparticles. FTIR and DSC studies revealed no interactions between drug and excipients. In-vitro release profiles indicated that, irrespective of the polymer used, increase in concentration has drastically retarded the release of stavudine. The mechanism of drug release was Non-Fickian diffusion controlled first order kinetics for optimized formulation. Stability studies indicated that, the prepared nanoparticle remained more stable at room temperature after one month.

UR - http://www.scopus.com/inward/record.url?scp=84875983344&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875983344&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84875983344

VL - 31

SP - 1518

EP - 1522

JO - Latin American Journal of Pharmacy

JF - Latin American Journal of Pharmacy

SN - 0326-2383

IS - 10

ER -